LymphedemaV1, Main, Exploration, bibRecord, 005825

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

Identifieur interne : 005825 ( Main/Exploration ); précédent : 005824; suivant : 005826

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

Auteurs : David Cameron [Royaume-Uni] ; Michelle Casey [États-Unis] ; Cristina Oliva [Royaume-Uni] ; Beth Newstat [États-Unis] ; Bradley Imwalle [États-Unis] ; Charles E. Geyer [États-Unis]

Source :

The Oncologist [ 1083-7159 ] ; 2010.

RBID : PMC:3228041

Abstract

The article presents final analyses of overall survival from a phase III trial of lapatinib and capecitabine in patients with human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer that progressed following prior therapy including trastuzumab.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228041

DOI: 10.1634/theoncologist.2009-0181
PubMed: 20736298
PubMed Central: 3228041

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial</title>
<author><name sortKey="Cameron, David" sort="Cameron, David" uniqKey="Cameron D" first="David" last="Cameron">David Cameron</name>
<affiliation wicri:level="4"><nlm:aff id="aff1">University of Leeds, Leeds, United Kingdom;</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Leeds, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName><settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Casey, Michelle" sort="Casey, Michelle" uniqKey="Casey M" first="Michelle" last="Casey">Michelle Casey</name>
<affiliation wicri:level="2"><nlm:aff id="aff2">GlaxoSmithKline, Collegeville, Pennsylvania, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oliva, Cristina" sort="Oliva, Cristina" uniqKey="Oliva C" first="Cristina" last="Oliva">Cristina Oliva</name>
<affiliation wicri:level="3"><nlm:aff id="aff3">Takeda Pharmaceutical Company, Limited, London, United Kingdom;</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Takeda Pharmaceutical Company, Limited, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Newstat, Beth" sort="Newstat, Beth" uniqKey="Newstat B" first="Beth" last="Newstat">Beth Newstat</name>
<affiliation wicri:level="2"><nlm:aff id="aff2">GlaxoSmithKline, Collegeville, Pennsylvania, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Imwalle, Bradley" sort="Imwalle, Bradley" uniqKey="Imwalle B" first="Bradley" last="Imwalle">Bradley Imwalle</name>
<affiliation wicri:level="2"><nlm:aff id="aff4">Health Learning Systems, Parsippany, New Jersey, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Health Learning Systems, Parsippany, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geyer, Charles E" sort="Geyer, Charles E" uniqKey="Geyer C" first="Charles E." last="Geyer">Charles E. Geyer</name>
<affiliation wicri:level="2"><nlm:aff id="aff5">Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">20736298</idno>
<idno type="pmc">3228041</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228041</idno>
<idno type="RBID">PMC:3228041</idno>
<idno type="doi">10.1634/theoncologist.2009-0181</idno>
<date when="2010">2010</date>
<idno type="wicri:Area/Pmc/Corpus">004252</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004252</idno>
<idno type="wicri:Area/Pmc/Curation">004251</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004251</idno>
<idno type="wicri:Area/Pmc/Checkpoint">003367</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">003367</idno>
<idno type="wicri:Area/Ncbi/Merge">003D22</idno>
<idno type="wicri:Area/Ncbi/Curation">003D22</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003D22</idno>
<idno type="wicri:doubleKey">1083-7159:2010:Cameron D:lapatinib:plus:capecitabine</idno>
<idno type="wicri:Area/Main/Merge">005877</idno>
<idno type="wicri:Area/Main/Curation">005825</idno>
<idno type="wicri:Area/Main/Exploration">005825</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial</title>
<author><name sortKey="Cameron, David" sort="Cameron, David" uniqKey="Cameron D" first="David" last="Cameron">David Cameron</name>
<affiliation wicri:level="4"><nlm:aff id="aff1">University of Leeds, Leeds, United Kingdom;</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Leeds, Leeds</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName><settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Casey, Michelle" sort="Casey, Michelle" uniqKey="Casey M" first="Michelle" last="Casey">Michelle Casey</name>
<affiliation wicri:level="2"><nlm:aff id="aff2">GlaxoSmithKline, Collegeville, Pennsylvania, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Oliva, Cristina" sort="Oliva, Cristina" uniqKey="Oliva C" first="Cristina" last="Oliva">Cristina Oliva</name>
<affiliation wicri:level="3"><nlm:aff id="aff3">Takeda Pharmaceutical Company, Limited, London, United Kingdom;</nlm:aff>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Takeda Pharmaceutical Company, Limited, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Newstat, Beth" sort="Newstat, Beth" uniqKey="Newstat B" first="Beth" last="Newstat">Beth Newstat</name>
<affiliation wicri:level="2"><nlm:aff id="aff2">GlaxoSmithKline, Collegeville, Pennsylvania, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>GlaxoSmithKline, Collegeville, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Imwalle, Bradley" sort="Imwalle, Bradley" uniqKey="Imwalle B" first="Bradley" last="Imwalle">Bradley Imwalle</name>
<affiliation wicri:level="2"><nlm:aff id="aff4">Health Learning Systems, Parsippany, New Jersey, USA;</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Health Learning Systems, Parsippany, New Jersey</wicri:regionArea>
<placeName><region type="state">New Jersey</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Geyer, Charles E" sort="Geyer, Charles E" uniqKey="Geyer C" first="Charles E." last="Geyer">Charles E. Geyer</name>
<affiliation wicri:level="2"><nlm:aff id="aff5">Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Human Oncology, Allegheny General Hospital, Pittsburgh, Pennsylvania</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">The Oncologist</title>
<idno type="ISSN">1083-7159</idno>
<idno type="eISSN">1549-490X</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The article presents final analyses of overall survival from a phase III trial of lapatinib and capecitabine in patients with human epidermal growth factor receptor 2–positive locally advanced or metastatic breast cancer that progressed following prior therapy including trastuzumab.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Moy, B" uniqKey="Moy B">B Moy</name>
</author>
<author><name sortKey="Goss, Pe" uniqKey="Goss P">PE Goss</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Joensuu, H" uniqKey="Joensuu H">H Joensuu</name>
</author>
<author><name sortKey="Kellokumpu Lehtinen, P L" uniqKey="Kellokumpu Lehtinen P">P-L Kellokumpu-Lehtinen</name>
</author>
<author><name sortKey="Bono, P" uniqKey="Bono P">P Bono</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Piccart Gebhart, Mj" uniqKey="Piccart Gebhart M">MJ Piccart-Gebhart</name>
</author>
<author><name sortKey="Procter, M" uniqKey="Procter M">M Procter</name>
</author>
<author><name sortKey="Leyland Jones, B" uniqKey="Leyland Jones B">B Leyland-Jones</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Romond, Eh" uniqKey="Romond E">EH Romond</name>
</author>
<author><name sortKey="Perez, Ea" uniqKey="Perez E">EA Perez</name>
</author>
<author><name sortKey="Bryant, J" uniqKey="Bryant J">J Bryant</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Slamon, D" uniqKey="Slamon D">D Slamon</name>
</author>
<author><name sortKey="Eiermann, W" uniqKey="Eiermann W">W Eiermann</name>
</author>
<author><name sortKey="Robert, N" uniqKey="Robert N">N Robert</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Slamon, Dj" uniqKey="Slamon D">DJ Slamon</name>
</author>
<author><name sortKey="Leyland Jones, B" uniqKey="Leyland Jones B">B Leyland-Jones</name>
</author>
<author><name sortKey="Shak, S" uniqKey="Shak S">S Shak</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Nahta, R" uniqKey="Nahta R">R Nahta</name>
</author>
<author><name sortKey="Esteva, Fj" uniqKey="Esteva F">FJ Esteva</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Rusnak, Dw" uniqKey="Rusnak D">DW Rusnak</name>
</author>
<author><name sortKey="Lackey, K" uniqKey="Lackey K">K Lackey</name>
</author>
<author><name sortKey="Affleck, K" uniqKey="Affleck K">K Affleck</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Geyer, Ce" uniqKey="Geyer C">CE Geyer</name>
</author>
<author><name sortKey="Forster, J" uniqKey="Forster J">J Forster</name>
</author>
<author><name sortKey="Lindquist, D" uniqKey="Lindquist D">D Lindquist</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cameron, D" uniqKey="Cameron D">D Cameron</name>
</author>
<author><name sortKey="Casey, M" uniqKey="Casey M">M Casey</name>
</author>
<author><name sortKey="Press, M" uniqKey="Press M">M Press</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Therasse, P" uniqKey="Therasse P">P Therasse</name>
</author>
<author><name sortKey="Arbuck, Sg" uniqKey="Arbuck S">SG Arbuck</name>
</author>
<author><name sortKey="Eisenhauer, Ea" uniqKey="Eisenhauer E">EA Eisenhauer</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Henderson, Ic" uniqKey="Henderson I">IC Henderson</name>
</author>
<author><name sortKey="Patek, Aj" uniqKey="Patek A">AJ Patek</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Di Leo, A" uniqKey="Di Leo A">A Di Leo</name>
</author>
<author><name sortKey="Gomez, Hl" uniqKey="Gomez H">HL Gomez</name>
</author>
<author><name sortKey="Aziz, Z" uniqKey="Aziz Z">Z Aziz</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Johnston, S" uniqKey="Johnston S">S Johnston</name>
</author>
<author><name sortKey="Pippen, J" uniqKey="Pippen J">J Pippen</name>
</author>
<author><name sortKey="Pivot, X" uniqKey="Pivot X">X Pivot</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
<li>New Jersey</li>
<li>Pennsylvanie</li>
<li>Yorkshire-et-Humber</li>
</region>
<settlement><li>Leeds</li>
<li>Londres</li>
</settlement>
<orgName><li>Université de Leeds</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Cameron, David" sort="Cameron, David" uniqKey="Cameron D" first="David" last="Cameron">David Cameron</name>
</region>
<name sortKey="Oliva, Cristina" sort="Oliva, Cristina" uniqKey="Oliva C" first="Cristina" last="Oliva">Cristina Oliva</name>
</country>
<country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Casey, Michelle" sort="Casey, Michelle" uniqKey="Casey M" first="Michelle" last="Casey">Michelle Casey</name>
</region>
<name sortKey="Geyer, Charles E" sort="Geyer, Charles E" uniqKey="Geyer C" first="Charles E." last="Geyer">Charles E. Geyer</name>
<name sortKey="Imwalle, Bradley" sort="Imwalle, Bradley" uniqKey="Imwalle B" first="Bradley" last="Imwalle">Bradley Imwalle</name>
<name sortKey="Newstat, Beth" sort="Newstat, Beth" uniqKey="Newstat B" first="Beth" last="Newstat">Beth Newstat</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005825 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005825 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3228041
   |texte=   Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20736298" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

Lapatinib Plus Capecitabine in Women with HER-2–Positive Advanced Breast Cancer: Final Survival Analysis of a Phase III Randomized Trial

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.